Logo Logo
Switch Language to German
Mittendorf, E. A.; Barrios, C. H.; Harbeck, N.; Jung, K. H.; Miles, D.; Saji, S.; Zhang, H.; Duc, A-N.; Rafii, S.; Lai, C. (2017): IMpassion031: A phase III study comparing neoadjuvant atezolizumab (atezo) vs placebo in combination with anthracycline/nab- paclitaxel (nab-pac)-based chemotherapy in early triple-negative breast cancer (eTNBC). In: Annals of Oncology, Vol. 28
Full text not available from 'Open Access LMU'.